Publication:
Cystic fibrosis patients eligible for modulator drugs: Data from cystic fibrosis registry of Turkey

Simple item page
dc.contributor.authorÇobanoğlu, Fatma Nazan
dc.contributor.authorErsöz, Deniz Doğru
dc.contributor.authorÇakır, Erkan
dc.contributor.authorEyüboğlu, Tuğba Şişmanlar
dc.contributor.authorPekcan, Sevgi
dc.contributor.authorCinel, Güzin
dc.contributor.authorYalçın, Ebru
dc.contributor.authorKiper, Nural
dc.contributor.authorŞen, Velat
dc.contributor.authorŞen, Hadice Selimoglu
dc.contributor.authorErcan, Ömur
dc.contributor.authorKeskin, Özlem
dc.contributor.authorEltan, Sevgi Bilgic
dc.contributor.authorAl Shadfan, Lina Muhammed
dc.contributor.authorYazan, Hakan
dc.contributor.authorAltintas, Derya Ufuk
dc.contributor.authorSasihuseyinoglu, Senay
dc.contributor.authorSapan, Nihat
dc.contributor.authorÇekiç, Şükrü
dc.contributor.authorCokugras, Haluk
dc.contributor.authorAtabek, Ayse Ayzit
dc.contributor.authorGursoy, Tugba Ramasli
dc.contributor.authorAslan, Ayse Tana
dc.contributor.authorBingol, Aysen
dc.contributor.authorBasaran, Abdurrahman Erdem
dc.contributor.authorÖzdemir, Ali
dc.contributor.authorKose, Mehmet
dc.contributor.authorHangul, Melih
dc.contributor.authorEmiralioglu, Nagehan
dc.contributor.authorTugcu, Gokcen
dc.contributor.authorYuksel, Hasan
dc.contributor.authorYilmaz, Özge
dc.contributor.authorOrhan, Fazil
dc.contributor.authorAydin, Zeynep Gokce Gayretli
dc.contributor.authorTopal, Erdem
dc.contributor.authorTamay, Zeynep
dc.contributor.authorSüleyman, Ayşe
dc.contributor.authorCan, Demet
dc.contributor.authorBal, Cem Murat
dc.contributor.authorCaltepe, Gönül
dc.contributor.authorÖzçelik, Ugur
dc.contributor.buuauthorSAPAN, NİHAT
dc.contributor.buuauthorÇEKİÇ, ŞÜKRÜ
dc.contributor.departmentTıp Fakültesi
dc.contributor.departmentÇocuk İmmünoloji ve Alerji Hastalıkları Ana Bilim Dalı
dc.contributor.orcid0000-0002-9574-1842
dc.contributor.researcheridFUI-8766-2022
dc.contributor.researcheridL-1933-2017
dc.date.accessioned2024-12-03T09:05:46Z
dc.date.available2024-12-03T09:05:46Z
dc.date.issued2019-09-28
dc.descriptionBu çalışma, Eylül 28-Ekim 02, 2019 tarihlerinde Madrid[İspanya]’da düzenlenen International Congress of the European-Respiratory-Society (ERS) Kongresi‘nde bildiri olarak sunulmuştur.
dc.description.sponsorshipEuropean Respiratory Soc
dc.identifier.doi10.1183/13993003.congress-2019.PA4518
dc.identifier.issn0903-1936
dc.identifier.issueSupplement 63
dc.identifier.urihttps://doi.org/10.1183/13993003.congress-2019.PA4518
dc.identifier.urihttps://publications.ersnet.org/content/erj/54/suppl63/pa4518
dc.identifier.urihttps://hdl.handle.net/11452/48824
dc.identifier.volume54
dc.identifier.wos000507372406030
dc.indexed.wosWOS.SCI
dc.indexed.wosWOS.ISTP
dc.language.isoen
dc.publisherEuropean Respiratory Soc Journals Ltd
dc.relation.journalEuropean Respiratory Journal
dc.relation.publicationcategoryMakale - Uluslararası Hakemli Dergi
dc.rightsinfo:eu-repo/semantics/closedAccess
dc.subjectRespiratory system
dc.titleCystic fibrosis patients eligible for modulator drugs: Data from cystic fibrosis registry of Turkey
dc.typeMeeting Abstract
dspace.entity.typePublication
local.contributor.departmentTıp Fakültesi/Çocuk İmmünoloji ve Alerji Hastalıkları Ana Bilim Dalı
relation.isAuthorOfPublicationcc312521-b6b8-4031-a0a0-b06b35291a1c
relation.isAuthorOfPublicationca52bf41-6be5-42a5-b2c5-f219305eba24
relation.isAuthorOfPublication.latestForDiscoverycc312521-b6b8-4031-a0a0-b06b35291a1c

Files

Collections

Yeni Yayınlar